Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT201512315280N22
IRCT201512315280N22
Completed
未知

Efficacy and Safety of Augmenting Autologous Bone Marrow Stem Cell Therapy in Routine Treatment of Children with Autism Spectrum Disorder: A Randomized Clinical Trial

Mashhad University of Medical Sciences0 sites36 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAutism.Childhood autism

Overview

Phase
未知
Intervention
Not specified
Conditions
Autism.
Sponsor
Mashhad University of Medical Sciences
Enrollment
36
Status
Completed
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •age range of \=5 and \=15 years
  • •a definite diagnosis of ASD based on DSM

Exclusion Criteria

  • •a long history of allergic reactions
  • •seizures during the past six months
  • •brain trauma
  • •moderate to severe extrapyramidal symptoms and tardive dyskinesia
  • •severe self\-injury behavior
  • •autoimmune diseases
  • •severe hematologic and pulmonary disease (such as pneumonia, asthma, malignancy and immune deficiency)
  • •severe focal or systemic infection (such as AIDS, hepatitis and syphilis)
  • •kidney and liver problems
  • •anemia and hemoglobin level less than 8 g/dL

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Investigation of the Effect of Stem Cells Injection in Children with Cerebral Palsy
IRCT20200502047277N5Shahid Beheshti University of Medical Sciences46
Completed
Not Applicable
A safety and efficacy study of autologous bone marrow cell transplantation for cirrhosis of liver caused by lifestyle related diseaseCirrhosis of liver caused by lifestyle related disease(Including NASH)
JPRN-UMIN000015251Heart life hospital10
Completed
Not Applicable
A safety and efficacy study of autologous bone marrow cell transplantation for HIV positive patients with cirrhosisHIV infection, AIDS, Cirrhosis
JPRN-UMIN000005174ational Center for Global Health and Medicine10
Recruiting
Phase 1
Autologous Mesenchymal Stem Cell Therapy in LupusHealth Condition 1: null- Systemic lupus erythematosus
CTRI/2015/04/005716KIMS Foundation and Research Center and Krishna Institute of Medical Sciences10
Suspended
Phase 2
Safety and efficacy of allogeneic bone as a bone filling material for sinus floor augmentatio
JPRN-jRCTs072210054Ohba Seigo10